期刊文献+

补肾降浊方治疗慢性肾脏病2-3期肾虚浊瘀证临床疗效观察 被引量:5

Clinical observation on“Bushen Jiangzhuo Decoction”for the treatment of chronic kidney disease at 2-3 phase of kidney deficiency and blood stasis pattern
下载PDF
导出
摘要 目的观察补肾降浊方治疗慢性肾脏病(CKD)2-3期肾虚浊瘀证的临床疗效。方法采用前瞻性随机对照研究,将90例CKD 2-3期肾虚浊瘀证患者分为2组,对照组仅予基础治疗,治疗组予基础治疗联合补肾降浊方,疗程3个月。观察两组治疗前后中医证候积分24h尿蛋白定量、血肌酐、尿素氮、血清胱抑素、血清白蛋白、血红蛋白、C反应蛋白等变化情况,以及临床疗效和残存肾功能情况。结果治疗组、对照组总有效率分别为93.33%、73.33%,两组临床疗效差异有统计学意义(P<0.05)。两组治疗前后中医证候积分均较治疗前降低(P<0.05),治疗组低于对照组(P<0.05,P<0.01)。治疗组治疗后Scr、BUN、24h尿蛋白定量、血清胱抑素C和C反应蛋白显著低于对照组,Hb、Alb高于对照组(P<0.05,P<0.01)。结论补肾降浊方联合基础治疗能显著改善CKD2-3期肾虚浊瘀证患者的24h尿蛋白定量、血清胱抑素C和C反应蛋白水平,降低Scr、BUN水平,改善肾功能,提高患者的Hb、Alb,改善贫血和肾性营养不良,延缓CKD 2-3期发展至终末期肾衰的进程。 Objective To observe the clinical effieaey of " Bushen Jiangzhuo Decoction" in treating chronic kidney disease (CKD) at 2-3 phase of kidney deficiency and blood stasis pattern. Methods Ninty eases with CKD at 2-3 phase were divided into two groups by prospective randomized controlled trial method. The eases in control group were treated with routine treatment, and cases in treatment group were treated with "Bushen Jiangzhuo Decoction" additionally, with the course of 3 months. The 24 hour urine protein, Ser, BUN, Cys, Alb, HB, CRP clinical efficacy and residual renal function were analyzed. Results The overall effeetive rate was 93.33% in the treatment group and 73.33% in the control group, with a dil't〉renee between tile two groups (P 〈 0.05 ). The clinieal symptom scores were decreased after treatment in both of the groups ( P 〈 0.05 ), the clinieal symptoms were impruved mueh more in treatment group than that of the eontrul group ( P 〈 0.01, P 〈 0.05 ). The contents of Scr, BUN, 24 hour urine protein, CYS-C and CRP in treatment gruup were lower than that of the control group, while the Hb and Atb were higher than that of the control group (P 〈 0.05, P 〈 0.01 ). Conclusion Comhined " Bushen Jiangzhuo Decoction" and routine treatment can improve the levels of 24 h urine protein quantitation, CYS-C and CRP significantly. It can also decrease the Scr and BUN, improve the kidney function, Hb, Alb, anemia, renal osteodystrophy and retard the developing process of CKD 2-3 phase to end-stage renal failure.
出处 《上海中医药杂志》 2013年第12期33-36,共4页 Shanghai Journal of Traditional Chinese Medicine
基金 上海市中医临床优势专科建设项目(ZYSNXD-YL-YSZK024)
关键词 慢性肾脏病2-3期 肾虚浊瘀证 补肾降浊方 临床疗效 chronic kidney disease kidney deficiency and blood stasis pattern "Bushen Jiangzhuo Deeuction" elinical effieaey
  • 相关文献

参考文献7

二级参考文献18

  • 1金周慧,陈以平,邓跃毅.蝉花菌丝延缓肾小球硬化的作用机制研究[J].中国中西医结合肾病杂志,2005,6(3):132-136. 被引量:37
  • 2王海燕 郑法雷 等.原发性肾小球疾病分型与治疗及诊断标准专题座谈会纪要[J].中华内科杂志,1993,2:131-134. 被引量:682
  • 3[1]Poteryaeva ON, Falameeva OV, Zhanaeva SY, et al. Role of cystatin C and cysteine proteinases in the development of mouse LS-lymphosaroma[J]. Bull-Exp-Biol-Med,2001,132(1 ):675-7. 被引量:1
  • 4[2]Kazama J J, Kutsuwada K, Ataka K. Serum cystatin C reliably detects renal dysfunction in patients with various renal diseases[J]. Nephron,2002,91 ( 1 ): 13-20. 被引量:1
  • 5[3]Wu XC, Yi ZW, He X J, et al. Pathological quantitaniue analysis of kidney in purpura nephritis of children[J]. Hu Nan Yi Ke Da Xue Xue Bao, 2000,25(4):403-405. Chinese. 被引量:1
  • 6[4]Mezzano SA, Drougett MA, Burgos ME, et al. Overexpression of chemokines, fibrogenic, cytokines, and myofibroblasts in human mebmbranous nephropathy[J].Kidney Int,2000,57:147-158. 被引量:1
  • 7[5]Tang X, Yuan FH. Relationship between expression of tissre inhibitor of metalloproteinase-1 and matrix metalloproteinase-9 and renal fibrosis[J]. Zhong Guo Xian Dai Yi Xue Za Zhi, 2002,12(2):13-15. Chinese. 被引量:1
  • 8[6]Lukasiuk K, Pirttila TJ, Pitkanen A. Upregulation of cystatin C expression in the rat hippocampus during epileptogenesis in the amygdala stimulation moldel of temporal lobe epilepsy[J]. Epilepsia,2002,43 Suppl (5):137-45. 被引量:1
  • 9[7]Shimizu TA, Kobata M, Io H, et al. Serum cystatin C is a more sensitive marker of glomerular function than serum creatinine [J].Nephron,2002,92(1 ):224-6. 被引量:1
  • 10[8]Takeuchi M, Fukuda Y, Nakano I, et al. Elevation of serum cystatin C concentrations in patients with chronic liver disease[J].Eur J Gastroenterol Hepatol,2001,13(8):951-5. 被引量:1

共引文献588

同被引文献49

引证文献5

二级引证文献32

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部